About this trial
The goal of this clinical trial is to learn immediate and follow up results of percutaneous treatment of coronary bifurcation lesion using drug eluting balloons (DEB) only in patients with chronic coronary syndrome (CCS). Researchers will compare endovascular treatment using solely DEB to stenting of coronary bifurcation lesion. The main questions it aims to answer are:
* What is immediate and follow up clinical and angiographic results of endovascular treatment of coronary bifurcation lesion using DEB in patients with CCS? * Is efficacy and safety of endovascular treatment of coronary bifurcation lesion using DEB only in patients with CCS non inferior to compare stenting of aforementioned lesion which is contemporary recommended standard of care?
Participants will:
* Take prescribed medication before and after initial procedure during whole observation period (12 months) * Visit the clinic at 1, 6 and 12 months after the initial procedure for checkup, noninvasive tests and control angiography at 12 months follow up * Inform researchers about all adverse events that might be occur during follow up observation period
Eligibility criteria
Qualifiers
Patients with CCS with documented myocardial ischemia in area supplying by the target coronary artery, not older than 80 years and with an expected life expectancy of at least 1 year
Patients with single- or multivessel disease and "true" (1.1.1; 1.1.0; and 0.1.1 according to the Medina classification) de novo bifurcation stenosis > 50% and <100% of the main coronary artery (excluding of the left main) or their large side branches.
Both main and side branches should be ≥ 2.0 mm and ≤ 4.5 mm in diameter (according to Quantitative coronary angiography - QCA or intravascular imaging)
Length of the main branch lesion should be no more than 30 mm
Disqualifiers
Patients with a single remaining artery supplying a large area of myocardium at risk, regardless of its caliber
Over 80 years of age
Bifurcation stenosis of the left main coronary artery and bifurcation lesions other than 1.1.1; 1.0.1, and 0.1.1 according to the Medina classification
The difference between the proximal and distal reference diameter of the main artery is > 1 mm
Trial design
Treatments tested in this trial
- Balloon Angioplasty with or without drug administration
Treatment groups
Locations
Sponsors and collaborators
Avtandil M. Babunashvili
Lead sponsor
Center of Endosurgery and Lithotripsy, Moscow, Russia
Sponsor institution
I.M. Sechenov First Moscow State Medical University
Collaborator